HICKEN; Erik James

Patent Applications and Registrations

Patent applications and USPTO patent grants for HICKEN; Erik James.The latest application filed is for "compounds for the treatment of braf-associated diseases and disorders".

Company Profile

7.18.19

HICKEN; Erik James - Longmont CO
Hicken; Erik James - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds For The Treatment Of Braf-associated Diseases And Disorders App 20220289721 - BARBOUR; Patrick Michael ; et al.	2022-09-15
Compounds for the treatment of BRAF-associated diseases and disorders Grant 11,414,404 - Barbour , et al. August 16, 2	2022-08-16
KRAS G12C inhibitors Grant 11,267,812 - Fischer , et al. March 8, 2	2022-03-08
Kras G12c Inhibitors App 20210380570 - Marx; Matthew Arnold ; et al.	2021-12-09
Kras G12c Inhibitors App 20210269432 - FISCHER; John P. ; et al.	2021-09-02
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 11,028,093 - Allen , et al. June 8, 2	2021-06-08
Compounds For The Treatment Of Braf-associated Diseases And Disorders App 20200407344 - BARBOUR; Patrick Michael ; et al.	2020-12-31
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20200291039 - Allen; Shelley ; et al.	2020-09-17
4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Grant 10,730,880 - Allen , et al.	2020-08-04
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 10,669,269 - Boys , et al.	2020-06-02
KRas G12C inhibitors Grant 10,633,381 - Blake , et al.	2020-04-28
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20190177328 - Allen; Shelley ; et al.	2019-06-13
Kras G12c Inhibitors App 20190062330 - Blake; James F. ; et al.	2019-02-28
4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 10,189,845 - Allen , et al. Ja	2019-01-29
KRas G12C inhibitors Grant 10,125,134 - Blake , et al. November 13, 2	2018-11-13
SUBSTITUTED N-(lH-INDAZOL-4-YL)IMIDAZO[l,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20180086758 - Boys; Mark Laurence ; et al.	2018-03-29
Kras G12c Inhibitors App 20180072723 - Blake; James F. ; et al.	2018-03-15
4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20170362240 - Allen; Shelley ; et al.	2017-12-21
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,809,590 - Boys , et al. November 7, 2	2017-11-07
Serine/threonine kinase inhibitors Grant 9,670,208 - Blake , et al. June 6, 2	2017-06-06
Serine/threonine Kinase Inhibitors App 20160304519 - Blake; James F. ; et al.	2016-10-20
SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS TYPE III RECEPTOR TYROSINE KINASE INHIBITORS App 20160002232 - Boys; Mark Laurence ; et al.	2016-01-07
Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type III receptor tyrosine kinase inhibitors Grant 9,174,981 - Boys , et al. November 3, 2	2015-11-03
Triazolopyridine compounds as PIM kinase inhibitors Grant 8,987,251 - Allen , et al. March 24, 2	2015-03-24
Triazolopyridine compounds as PIM kinase inhibitors Grant 8,895,550 - Allen , et al. November 25, 2	2014-11-25
5,7-substituted-imidazo[1,2-c]pyrimidines App 20140228349 - Boys; Mark Laurence ; et al.	2014-08-14
Triazolopyridine Compounds As Pim Kinase Inhibitors App 20140045835 - Allen; Shelley ; et al.	2014-02-13
Triazolopyridine Compounds As Pim Kinase Inhibitors App 20140045817 - Allen; Shelley ; et al.	2014-02-13
Triazolopyridine compounds as PIM kinase inhibitors Grant 8,575,145 - Allen , et al. November 5, 2	2013-11-05
Substituted N-(1h-indazol-4-yl)imidazo[1,2-]pyridine-3-carboxamide Compounds As Type Iii Receptor Tyrosine Kinase Inhibitors App 20130274244 - Boys; Mark Laurence ; et al.	2013-10-17
Triazolopyridine compounds as PIM kinase inhibitors Grant 8,557,809 - Allen , et al. October 15, 2	2013-10-15
Triazolopyridine Compounds As Pim Kinase Inhibitors App 20110144100 - Allen; Shelley ; et al.	2011-06-16
Triazolopyridine Compounds As Pim Kinase Inhibitors App 20110144085 - Allen; Shelley ; et al.	2011-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.